Table 5.

Adjusted odd ratios of outcomes among ticagrelor and prasugrel users for proton pump inhibitor use vs. non-use at 12 months post cohort entry

Outcome	Ticagrelor users		Prasugrel users
	Cases/controls	OR (95% CI)	Cases/controls	OR (95% CI)
MI	251/1111	0.96 (0.69–1.33)	173/811	1.04 (0.67–1.61)
In-hospital mortality	131/548	0.82 (0.50–1.35)	75/340	0.85 (0.36–2.01)
Stroke	105/446	1.24 (0.68–2.27)	70/330	0.52 (0.19–1.42)
Composite endpoint	454/1960	0.93 (0.73–1.18)	304/1417	1.03 (0.74–1.42)

CI confidence interval, MI myocardial infarction, OR odds ratio